Clinical trials for Thalassemia
18 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07338344Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT PatientsRongrong Liu
- RECRUITINGN/ANCT07112703Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia MajorRawan Mohammed Khairy Mostafa Elsawy
- RECRUITINGPhase 3NCT06609226A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or ThalassaemiaNovo Nordisk A/S · PI: Clinical Transparency (dept. 2834)
- RECRUITINGN/ANCT06931912Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With ThalassemiaInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPhase 2NCT06657391Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent ThalassemiaRongrong Liu
- ENROLLING BY INVITATIONNCT07003269Observational Study: Hetrombopag for Platelet Recovery in Haploidentical HSCTHaikou Affiliated Hospital of Central South University Xiangya School of Medicine · PI: Xiaoyang Yang, MD
- ACTIVE NOT RECRUITINGNCT06596642A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in TaiwanBristol-Myers Squibb · PI: Bristol-Myers Squibb
- RECRUITINGPhase 1NCT06655662Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.Shenzhen Hemogen · PI: Chao Liu, PHD
- RECRUITINGPhase 2NCT06302491A Study of Safety and Efficiency of AND017 in Patients With β-thalassemiaKind Pharmaceuticals LLC · PI: Yusha Zhu, MD, PhD
- RECRUITINGN/ANCT06041620Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem CellsInstitute of Hematology & Blood Diseases Hospital, China · PI: Jun Shi, PhD
- RECRUITINGN/ANCT05776173Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemiaShanghai BDgene Co., Ltd. · PI: Sujiang Zhang, M.D.
- ACTIVE NOT RECRUITINGNCT06913634Study to Evaluate the Long- Term Safety and Efficacy of Luspatercept in Subjects Who Received at Least One Dose of Luspatercept in the Compassionate Use PhaseFondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia · PI: RAFFAELLA ORIGA
- RECRUITINGPhase 1NCT05757245A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia ParticipantsFirst Affiliated Hospital of Guangxi Medical University
- RECRUITINGNCT06314529Long-term Follow-up Study of BHC001 for TDTBioray Laboratories · PI: Xiaochen Wang, PhD
- RECRUITINGEarly Phase 1NCT05851105the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-ThalassemiaShenzhen Hemogen · PI: Chao Liu, PHD
- RECRUITINGEarly Phase 1NCT05864170the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-ThalassemiaShenzhen Hemogen · PI: Chao Liu, PHD
- ACTIVE NOT RECRUITINGPhase 2NCT03692052A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent ThalassemiaAgios Pharmaceuticals, Inc. · PI: Medical Affairs
- ACTIVE NOT RECRUITINGNCT03376893Epidemiology of Silent and Overt Strokes in Sickle Cell DiseaseVanderbilt University Medical Center · PI: Lori C. Jordan, PhD, MD